8
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Tumour Markers in Pancreatic Cancer

, , &
Pages 75-78 | Published online: 08 Jul 2009
 

Abstract

The serum levels of three new tumour markers defined by monoclonal antibodies, CA 19-9, CA 50 and CA 125, were analysed and compared with carcinoembryonic antigen (CEA) in samples from 91 patients with pancreatic cancer and from 111 patients with benign pancreatic, biliary tract and hepatocellular diseases. High serum concentrations of CA 19-9 and CA 50 were found in most patients with pancreatic cancer, 78% and 72%, respectively. The serum levels of these two markers showed a positive correlation, while no other correlation was found between the markers. Benign extrahepatic cholestasis was often associated with moderately elevated CA 19-9 and CA 50 levels. The CA 125 and CEA levels were elevated in about half of the patients with pancreatic cancer. Both CA 19-9 and CA 50 seem promising in the follow-up of patients with pancreatic cancer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.